{"meta":{"query_hash":"962595f0e19d","filters":{"venue":"Proceedings of Anticancer Research"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/962595f0e19d","api":"https://metacan.xera.ac/api/v1/cohort?venue=Proceedings+of+Anticancer+Research"},"results":[{"id":"W3116496863","doi":"10.26689/par.v3i2.919","title":"PEG-DOX, novel pH responsive prodrug nanoparticles","year":2019,"lang":"en","type":"article","venue":"Proceedings of Anticancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Prodrug; Nanocarriers; PEG ratio; Doxorubicin; Polyethylene glycol; Chemistry; Amphiphile; Nanoparticle; Solubility; Adept; Combinatorial chemistry; Drug delivery; Biophysics; Nanotechnology; Biochemistry; Materials science; Organic chemistry; Chemotherapy; Polymer; Copolymer","score_opus":0.0471468644350775,"score_gpt":0.33897887693865275,"score_spread":0.29183201250357527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116496863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91356194,0.009562284,0.062365565,0.00062756275,0.0002043739,0.00040013017,0.0008436444,0.000956273,0.011478275],"genre_scores_gemma":[0.96405756,0.0022587546,0.020319745,0.00023616492,0.000027690838,0.00009637522,0.00049668323,0.000048729573,0.012458341],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999409,0.000006779006,0.000006196454,0.000021806401,0.000014187788,0.00001018224],"domain_scores_gemma":[0.99997234,0.0000042055813,0.0000097317725,0.000002500351,0.0000041062985,0.000007115932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008782475,0.0003033633,0.00015584262,0.00011160093,0.000084289066,0.00017839951,0.00018389623,0.00030141906,0.00071301113],"category_scores_gemma":[0.00009099439,0.00014616428,0.00010298578,0.00006625983,0.00012993056,0.00031684115,0.00014328322,0.0002554291,0.00047927577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006784786,0.000025132958,0.000070109476,0.00006901964,0.0000031035934,0.00012037055,0.000012402125,0.00025619488,0.99415696,0.00032119238,0.0001300645,0.004767697],"study_design_scores_gemma":[0.000026867634,0.00013904565,0.00046168294,0.000004151488,0.0000061917904,0.00036991562,0.0000048973247,0.001245345,0.99085677,0.00008224069,0.0067983484,0.000004662901],"about_ca_topic_score_codex":0.0003466151,"about_ca_topic_score_gemma":0.00057357614,"teacher_disagreement_score":0.00071301113,"about_ca_system_score_codex":0.00035892683,"about_ca_system_score_gemma":0.00016484634,"threshold_uncertainty_score":0.0026041865},"labels":[],"label_agreement":null},{"id":"W3204355507","doi":"10.26689/par.v5i5.2502","title":"Lopinavir/Ritonavir in the Treatment of COVID-19: A Systematic Review and Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"Proceedings of Anticancer Research","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lopinavir; Ritonavir; Medicine; Meta-analysis; Inclusion and exclusion criteria; Lopinavir/ritonavir; Coronavirus disease 2019 (COVID-19); Internal medicine; Adverse effect; Pharmacology; Virology; Viral load; Human immunodeficiency virus (HIV); Alternative medicine; Pathology; Antiretroviral therapy","score_opus":0.5158164153192062,"score_gpt":0.6252725909002165,"score_spread":0.10945617558101028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204355507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001712759,0.9974481,0.00017607117,0.00011449611,0.00007106222,0.00016256985,0.00017229226,0.0000095326795,0.00013313841],"genre_scores_gemma":[0.05179089,0.9453936,0.0010291095,0.00046111437,0.00016574143,0.0006240805,0.00033336866,0.000012352188,0.00018970913],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99379843,0.002777193,0.0018690875,0.00052915525,0.00078230817,0.00024389902],"domain_scores_gemma":[0.98899347,0.0075420975,0.0020250506,0.00024870734,0.0010086923,0.00018194602],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0093213925,0.002319164,0.016622702,0.007953059,0.0005845981,0.0026400678,0.0019006224,0.0018410041,0.0037421177],"category_scores_gemma":[0.019209344,0.0012065673,0.022211313,0.008924242,0.0005518003,0.0015049753,0.0012378007,0.0012629307,0.0002672404],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011265442,0.00003435869,0.0024713073,0.70292425,0.27482182,0.00014348899,0.00007964869,0.00029948683,0.00025232046,0.00014011534,0.0006665903,0.017040044],"study_design_scores_gemma":[0.00047696588,0.00026880184,0.0038779106,0.0818688,0.9092197,0.00014751463,0.00006960187,0.00017954984,0.0001487757,0.00016991058,0.0035480573,0.000024480787],"about_ca_topic_score_codex":0.0056233155,"about_ca_topic_score_gemma":0.014283317,"teacher_disagreement_score":0.9833773,"about_ca_system_score_codex":0.0023080376,"about_ca_system_score_gemma":0.004696058,"threshold_uncertainty_score":0.049296796},"labels":[],"label_agreement":null},{"id":"W4309315777","doi":"10.26689/par.v6i6.4512","title":"Analysis of the Epigenetic Mechanism and Treatment of Huntington’s Disease","year":2022,"lang":"en","type":"article","venue":"Proceedings of Anticancer Research","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Johns Hopkins University","keywords":"Huntington's disease; Epigenetics; Huntingtin; Chorea; Mechanism (biology); Disease; Genetics; Biology; DNA methylation; Huntingtin Protein; Medicine; Neuroscience; Gene; Bioinformatics; Internal medicine","score_opus":0.0820955173788085,"score_gpt":0.3564727701221637,"score_spread":0.2743772527433552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309315777","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6729218,0.29768568,0.010721248,0.0024394162,0.00072160474,0.0002985901,0.00054721575,0.00019583481,0.014468696],"genre_scores_gemma":[0.8988262,0.08969054,0.0039531924,0.00077492994,0.00021596061,0.00014117718,0.00048676014,0.00002226733,0.005888987],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999515,0.0000101230735,0.0000042848296,0.000010681944,0.0000144585165,0.00000899781],"domain_scores_gemma":[0.9999734,0.000005690233,0.0000065784075,0.000002485779,0.0000067510905,0.0000050556723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018754744,0.00013419014,0.00024094523,0.00021519343,0.00011289229,0.00018400497,0.0002017305,0.00022961461,0.0013253082],"category_scores_gemma":[0.00013727987,0.0000626925,0.0002545978,0.00013273946,0.0001441805,0.00016379094,0.0001431161,0.00042934908,0.00014859656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019995666,0.0010041952,0.0028792287,0.0017150436,0.00028385143,0.00043187838,0.00014907963,0.00097514916,0.50196123,0.0034313614,0.0031597938,0.48200968],"study_design_scores_gemma":[0.0012928303,0.022991823,0.05891907,0.00068030803,0.0012050193,0.0025551007,0.0003788637,0.0054416745,0.689127,0.004174225,0.21316823,0.000065972206],"about_ca_topic_score_codex":0.00032034836,"about_ca_topic_score_gemma":0.0010388255,"teacher_disagreement_score":0.0013253082,"about_ca_system_score_codex":0.00019154616,"about_ca_system_score_gemma":0.0001917777,"threshold_uncertainty_score":0.0044335723},"labels":[],"label_agreement":null}]}